All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: tni.ohw@snoissimrep).
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Overview
A new test for diagnosing diabetes mellitus has been accepted by a WHO-backed group of experts, offering a more practical approach to test for the disease that affects over 220 million people worldwide. The report recommends the acceptability of glycated haemoglobin, or HbA1c, as an additional test to diagnose this debilitating and deadly disease.
Contents
- Executive Summary
- 1. Introduction
- 2. Glycated haemoglobin (HbA1c) for the diagnosis of diabetes
- Annex 1 Some of the factors that influence HbA1c and its measurement
- Annex 2 Advantages and disadvantages of various HbA1c assay methods
- Annex 3 Advantages and disadvantage of assays for glucose and HbA1c
- Annex 4 External experts
- Systematic review
The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- NLM CatalogRelated NLM Catalog Entries
- Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes MellitusUse of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus
Your browsing activity is empty.
Activity recording is turned off.
See more...